Minimum Appropriate Follow-Up Reduces Mortality After Endoprosthesis Implantation

No study has been able to prove long-term benefit of regular imaging follow-up after abdominal aortic aneurysm repair by means of endoprosthesis implantation. This is important because the costs for these studies are high, which should be added to potential radiation and contrast morbidity.

Un seguimiento mínimo y apropiado reduce la mortalidad luego de una endoprótesis

This work sought to characterize the association between post-endovascular abdominal aortic aneurysm repair imaging frequency and long-term survival.

 

Minimum appropriate imaging follow-up was defined as a computerized tomography (CT) scan or ultrasound of the abdomen within 90 days of the procedure, as well as every 15 months thereafter. A multivariate analysis was conducted to determine the association between compliance with minimum appropriate imaging follow-up over time and all-cause mortality.


Read also: Polymer-Free DES Also Show Efficacy in Anticoagulated Patients with High Risk for Bleeding”.


The study enrolled 4988 patients treated with an endoprosthesis, and the mean follow-up was 3.4 years. Ninety-day mortality was 1.6%. Among those who survived over 90 days, 87% (n = 4251 of 4902) underwent at least one CT scan or ultrasound of the abdomen within 3 months, but only 58% (n = 2859 of 4902) came back afterwards to meet minimum appropriate imaging follow-up criteria.

 

Infrequent imaging correlated with lower follow-up by an interventional cardiologist or the vascular surgeon who performed the implantation, but not with infrequent primary care. Patients continued visiting their primary care physician, who did not refer them to specialists in a timely manner for minimum appropriate follow-up for their abdominal aortic aneurysm.

 

Consistently meeting minimum appropriate follow-up criteria was associated with a lower mortality rate when compared with patients who did not undergo a scan within 90 days (hazard ratio [HR]: 0.82; 95% confidence interval [CI]: 0.69-0.96; p = 0.014), or when compared with patients who underwent a first imaging follow-up within 90 days but missed subsequent follow-up instances (HR: 0.78; 95% CI: 0.68-0.91; p = 0.001).


Read also: Pacemaker Implantation After TAVI Raises Costs But Not the Incidence of Adverse Events”.


The longer the patients remained within the minimum appropriate follow-up protocol, the lower the mortality rates.

 

Conclusion

These data support efforts to improve long term follow-up of patients who receive an endoprosthesis during infrarenal aortic aneurysm repair.

 

Editorial

The lower mortality rates observed with regular follow-up after prosthesis implantation can be partially explained by imaging studies. Imaging follow-up may actually be a subrogated endpoint, and reduced mortality may be a consequence of, for example, better control of cardiovascular risk factors, or a change in lifestyle after the procedure.

 

Patients who disregarded the follow-up still visited their primary care physician regularly, which means that there is an opportunity to improve communication with these physicians in order to obtain adequate imaging follow-up.

 

Original title: The Impact of Compliance with Imaging Follow-up on Mortality After Endovascular Abdominal Aortic Aneurysm Repair: A Population Based Cohort Study.

Reference: C. de Mestral et al. Eur J Vasc Endovasc Surg (2017). Article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

A New Asymptomatic Carotid Stenosis Paradigm? CREST-2 Trial Unified Results

Severe asymptomatic carotid stenosis continues to be controversial seeing the optimization of intensive medical therapy (IMT) and the availability lower periprocedural risk revascularization techniques....

Impact of Baseline Systolic Blood Pressure on Blood Pressure Changes Following Renal Denervation

Renal denervation (RDN) is a guideline-recommended therapy to reduce blood pressure in patients with uncontrolled hypertension, although uncertainties remain regarding which factors best predict...

Hypertriglyceridemia as Key Factor to Abdominal Aortic Aneurysm Development and Rupture: Genetic and Experimental Evidence

Abdominal aortic aneurysm (AAA) is a deadly vascular disease with no effective drug treatment, and risk of rupture reaching up to 80%. Even though...

Atrial Fibrillation and Chronic Kidney Disease: Outcomes of Different Stroke Prevention Strategies

Atrial fibrillation (AF) affects approximately 1 in every 4 patients with end-stage renal disease (ESRD). This population carries a high burden of comorbidities and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...